FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest more than $35 million ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Due to advances in technology and increased development of parenteral drugs, one of the fastest growing choices for drug delivery in the pharmaceutical industry is the prefilled syringe (PFS). Not ...

Viscosity-dependent behaviors such as drips, stringiness, and air entrapment can destabilize fill accuracy and visual inspection, necessitating tailored methodologies and tighter process controls.

Sharps Technology Inc. (NASDAQ: STSS) is pushing into the copolymer prefillable syringe market thanks to a deal with Nephron Pharmaceuticals Corp., a leader in contract manufacturing of generic ...

BD, a leading global medical technology company, is investing more than $35 million to expand prefilled flush syringe manufacturing at its Columbus, Neb., facility. With the investment, the company ...

The global dual chamber devices market presents growth opportunities driven by the rising demand for patient-friendly, accurate drug delivery systems, particularly in biologics. Advancements in ...